SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-16-015282
Filing Date
2016-05-13
Accepted
2016-05-13 16:06:58
Documents
54
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1601232_10q.htm 10-Q 474107
2 EXHIBIT 31.1 t1601232_ex31-1.htm EX-31.1 9542
3 EXHIBIT 31.2 t1601232_ex31-2.htm EX-31.2 9608
4 EXHIBIT 32.1 t1601232_ex32-1.htm EX-32.1 3357
5 EXHIBIT 32.2 t1601232_ex32-2.htm EX-32.2 3719
  Complete submission text file 0001571049-16-015282.txt   2646448

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cycc-20160331.xml EX-101.INS 406445
7 XBRL SCHEMA FILE cycc-20160331.xsd EX-101.SCH 31492
8 XBRL CALCULATION FILE cycc-20160331_cal.xml EX-101.CAL 31627
9 XBRL DEFINITION FILE cycc-20160331_def.xml EX-101.DEF 95369
10 XBRL LABEL FILE cycc-20160331_lab.xml EX-101.LAB 288687
11 XBRL PRESENTATION FILE cycc-20160331_pre.xml EX-101.PRE 190363
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 161648391
SIC: 2834 Pharmaceutical Preparations